2005Journal watchRequires access

Pimecrolimus vs. Tacrolimus: Which Is Better for Atopic Dermatitis?

Mary Wu Chang

Open publisher page 0 citations

Abstract

Pimecrolimus and tacrolimus are topical, nonsteroidal calcineurin inhibitors used in the treatment of atopic dermatitis. Pimecrolimus 1% cream is approved for patients at least 2 years old with mild-to-moderate atopic dermatitis. Tacrolimus 0.03% ointment is approved for patients at least 2 years old with moderate-to-severe atopic dermatitis, and tacrolimus 0.1% is approved for patients 16 years and older with moderate-to-severe atopic dermatitis. Few studies have compared these two …

About this research paper

What this paper is about

Pimecrolimus and tacrolimus are topical, nonsteroidal calcineurin inhibitors used in the treatment of atopic dermatitis. Pimecrolimus 1% cream is approved for patients at least 2 years old with mild-to-moderate atopic dermatitis. Tacrolimus 0.03% ointment is approved for patients at least 2 years old with moderate-to-severe atopic dermatitis, and tacrolimus 0.1% is approved for patients 16 years and older with moderate-to-severe atopic dermatitis. Few studies have compared these two …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Pimecrolimus and tacrolimus are topical, nonsteroidal calcineurin inhibitors used in the treatment of atopic dermatitis. Pimecrolimus 1% cream is approved for patients at least 2 years old with mild-to-moderate atopic dermatitis. Tacrolimus 0.03% ointment is approved for patients at least 2 years old with moderate-to-severe atopic dermatitis, and tacrolimus 0.1% is approved for patients 16 years and older with moderate-to-severe atopic dermatitis. Few studies have compared these two …

Key concepts: Pimecrolimus, Tacrolimus, Atopic dermatitis, Medicine, Dermatology, Calcineurin, Atopy, Allergy

Related papers

Back to paper searchBrowse research topicsOriginal source
Pimecrolimus vs. Tacrolimus: Which Is Better for Atopic Dermatitis? — Research Paper | ScholarLens